Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.

BACKGROUND The DNA repair gene XRCC4, a member of the protein family involved in non-homologous end-joining repair pathway, plays a major role in repairing DNA double-strand breaks. XRCC4 is important in maintaining the overall genome stability, and it is also thought to play a key role in human carcinogenesis. We investigated some novel polymorphic variants of XRCC4, including C-1622T (rs7727691), G-1394T (rs6869366), G-652T (rs2075685), C-571T (rs2075686), intron3 DIP (rs28360071), S247A (rs3734091) and intron7 DIP (rs28360317), and analyzed the association of specific genotype with susceptibility to childhood leukemia. MATERIALS AND METHODS In total, 266 children with leukemia and 266 age-matched healthy controls recruited from the China Medical Hospital in Central Taiwan were genotyped investigating the association of these polymorphisms with childhood leukemia. RESULTS We found differences in frequency of the XRCC4 G-1394T and intron 3 genotype, but not the XRCC4 codon 247, or intron 7, between the childhood leukemia and control groups. Our data indicated the G allele of G-1394T and deletion of intron 3 are clear risk factors of susceptibility to childhood leukemia (p=0.0022 and 0.0075). As for XRCC4 C-1622T and C-571T, there was no difference in the distribution between the two groups. The analysis of joint effect for XRCC4 G-1394T and intron 3 showed that individuals with GT at G-1394T and DD at intron 3 present the highest potential for developing childhood leukemia than other groups (odds ratio=4.94, 95% confidence interval=1.01-24.27, p=0.0404). CONCLUSION Our findings suggest that the G allele of XRCC4 G-1394T and deletion of intron 3 may be responsible for childhood leukemia and may be useful in early detection of child leukemia.

[1]  H. Wang,et al.  Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan. , 2009, Anticancer research.

[2]  Hsi-Chin Wu,et al.  Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.

[3]  Chia-Wen Tsai,et al.  Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. , 2009, Anticancer research.

[4]  M. Tsai,et al.  Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. , 2009, Oral oncology.

[5]  Mei-Due Yang,et al.  Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. , 2009, Anticancer research.

[6]  Hsi-Chin Wu,et al.  Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.

[7]  D. Bau,et al.  Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan. , 2009, Anticancer research.

[8]  Hsi-Chin Wu,et al.  Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.

[9]  Hsi-Chin Wu,et al.  Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.

[10]  M. Tsai,et al.  Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. , 2008, Oral oncology.

[11]  Da-Tian Bau,et al.  A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. , 2008, Oral oncology.

[12]  M. Tsai,et al.  Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. , 2008, Anticancer research.

[13]  Chen-Yang Shen,et al.  A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. , 2008, Anticancer research.

[14]  M. Tsai,et al.  A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. , 2008, Oral oncology.

[15]  D. Bau,et al.  A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan , 2008, Annals of Surgical Oncology.

[16]  Jeroen A. A. Demmers,et al.  Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4 , 2006, Proceedings of the National Academy of Sciences.

[17]  Chen-Yang Shen,et al.  The role of BRCA1 in non-homologous end-joining. , 2006, Cancer letters.

[18]  Nicola J. Camp,et al.  A Role for XRCC4 in Age at Diagnosis and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  Richard G. W. Anderson,et al.  Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization , 2005, Nature Cell Biology.

[20]  John N. Hutchinson,et al.  Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.

[21]  Chen-Yang Shen,et al.  Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1 , 2004, Cancer Research.

[22]  D. van Heemst,et al.  End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. , 2004, DNA repair.

[23]  K. Matsubara,et al.  [FISH detected 11q23 microdeletion and translocation at the long arm of chromosome 11 in a child with normal karyotypic acute lymphoblastic leukemia]. , 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[24]  P. Malfertheiner,et al.  Expression of caveolin-1 in gastrointestinal and extraintestinal cancers , 2003, Journal of Cancer Research and Clinical Oncology.

[25]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.

[26]  Pan‐Chyr Yang,et al.  Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.

[27]  P. Nathan,et al.  Isochromosome (17)(q10) and translocation (4;12)(q12;p13) in a child with acute myeloid leukemia. , 2001, Cancer genetics and cytogenetics.

[28]  M Dietel,et al.  Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. , 2001, The American journal of pathology.

[29]  T. Timme,et al.  Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis , 2000, Oncogene.

[30]  F. Alt,et al.  Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development , 2000, Nature.

[31]  J. Engelman,et al.  p42/44 MAP Kinase-dependent and -independent Signaling Pathways Regulate Caveolin-1 Gene Expression , 1999, The Journal of Biological Chemistry.

[32]  F. Alt,et al.  A Critical Role for DNA End-Joining Proteins in Both Lymphogenesis and Neurogenesis , 1998, Cell.

[33]  T. Seya,et al.  Expression of caveolin-1 in human T cell leukemia cell lines. , 1998, Biochemical and biophysical research communications.

[34]  Jan E Schnitzer,et al.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.

[35]  F. Alt,et al.  The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination , 1995, Cell.